Sanofi and Regeneron report positive skin disease trial

PARIS, June 6 (Reuters) - French drugmaker Sanofi SA

and U.S. partner Regeneron Pharmaceuticals Inc

said a one-year, late-stage study of dupilumab, a

monoclonal antibody designed for the treatment...

Read more